The ROCKET Shuttle Program

STUDY BASICS

Do you have atopic dermatitis? You may be eligible for a research study that aims to find out if a study drug may be well tolerated and effective for adults with atopic dermatitis. Compensation provided.

STUDY PURPOSE

The purpose of this research study is to measure how safe and effective a study drug may be in helping to control and reduce the signs and symptoms of atopic dermatitis. The study drug works by blocking certain inflammatory or immune responses seen in people with atopic dermatitis.

COULD THIS STUDY BE RIGHT FOR YOU?

• 18 years of age or older
• Diagnosed with moderate-to-severe atopic dermatitis for at least 6 months
• Experiencing signs and symptoms of your condition that are not manageable with your current treatment

WHAT PARTICIPANTS CAN EXPECT

If you meet the conditions the study is looking for and are enrolled, you will be in this study for a maximum of approximately 40 weeks (approximately 9 to 10 months). This includes:

• A screening period of a minimum of 8 days and up to 30 days.
• A study treatment period of approximately 20 weeks.
• A week 24 or End of Study Treatment visit at week 24 for participants who permanently discontinue the study drug for any reason during the study. Participants who permanently discontinue study drug early must complete the end of study treatment visit at the next visit following the last dose of the study drug.
• A safety follow-up visit that occurs approximately 16 weeks after the last dose of study drug (given in week 20) in case you do not continue into the long-term maintenance study.